Tony Blau

Summary

Tony Blau, MD, serves as a Professor of Hematology at the University of Washington School of Medicine in Seattle. Dr. Blau upholds a commitment to providing a superior level of care for each of his patients, as he also serves as an Attending Physician at the Seattle Cancer Care Alliance (SCCA). At SCCA, he cares for patients on the leukemia service. He also co-founded a not-for-profit organization called Partners in Personal Oncology.

Dr. Tony Blau maintains a strong interest in developing a personalized approach to cancer treatment, and this theme influences many areas of his professional endeavors. In his role as a Co-Director for the University of Washington’s Institute for Stem Cell and Regenerative Medicine (ISCRM), he conducts research on scientific discoveries in stem cells, gene therapy, and oncology, aiming to uncover new benefits and work toward a cure for current and future patients with cancer. Dr. Tony Blau and the other doctors at Partners in Personal Oncology foster a patient-centered philosophy that varies dramatically from those practiced in conventional oncology programs.

Some of the additional roles held by Dr. Tony Blau include positions as a member of the Fred Hutchinson/University of Washington Cancer Consortium and as a Co-Director for the Stem and Progenitor Cell Biology Program sponsored by that consortium. As for his many research efforts, Dr. Blau currently works on projects involving the use of molecular diagnostics to treat acute myeloid leukemia.

2005 - Present

Co-Founder and Chief Scientific Advisor

CellNexus, LLC

2010 - Present

Co-Founder and Executive Director

The breakthrough approaches we are developing are through the not-for-profit organization that I cofounded, Partners in Personal Oncology. My work in Partners in Personal Oncology does not yet involve seeing patients; rather, we are setting up the infrastructure and hope to enroll our first patient by mid next year.